Download Poster (723 KB)
- The implementation of IDS tool, which is integrated in the Epic, can assist providers in placing appropriate BBI insulin orders.
- Increased use of BBI use can result in reduction in hyperglycemia and hypoglycemia which can enhances overall patient safety and outcomes.
- Expanding or standardizing the intervention to other areas can help change prescriber practice and better glycemic control.
- Provider involvement and interest is an important factor in the utilization of the IDS tool.
Sigi Varghese pictured.
Varghese, Sigi APRN; Best, Conor MD; Lavis, Victor MD; Walton, Natalie C. MD; Sibille Senechalle, Michelle MD; Rizk, Michael APRN; Ortiz, Marjorie APRN; Brady, Veronica PhD, FNP-BC, BC-ADM, CDCES; Wilson, Mara APRN; Levesque, Celia APRN; Crowder, Vivian APRN; John, Benzy APRN; Saji, Lijo DNP, APRN; Williams, Jessica PA; and Thosani, Sonali MD, "Meeting Inpatient Glycemic Targets through Increased use of Basal Bolus Insulin Therapy" (2021). APRN Week Posters 2021. 11.